HEMGN (hemogen) is a nuclear protein that regulates hematopoietic cell proliferation and differentiation 1. It is a direct transcriptional target of HOXB4 and promotes expansion of myeloid progenitor cells 2. HEMGN expression is developmentally regulated through alternative promoters and polyadenylation, with distinct isoforms in hematopoietic cells and testis 1. At the molecular level, HEMGN upregulation by the transcriptional repressor Gfi1 occurs through repression of PU.1, contributing to anti-apoptotic activity independent of p53 3. HEMGN functions as a cancer/testis antigen with prognostic significance in multiple malignancies. In lung adenocarcinoma, high HEMGN expression correlates with better prognosis and associates with immune infiltration by B cells, CD8+ T cells, and dendritic cells 4. In FLT3-ITD-negative acute myeloid leukemia, high HEMGN expression predicts favorable outcomes 5. HEMGN also serves as a potential diagnostic biomarker for steroid-induced osteonecrosis of the femoral head, being downregulated in affected patients 6. In papillary thyroid carcinoma, the circ_PSD3/miR-637/HEMGN axis promotes tumor progression through PI3K/Akt pathway activation 7. HEMGN's role in various hematologic and solid tumors positions it as a clinically relevant biomarker for disease prognosis and potential therapeutic target.